http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#head http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://www.nanopub.org/nschema#hasAssertion http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://www.nanopub.org/nschema#hasProvenance http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#provenance http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://www.nanopub.org/nschema#hasPublicationInfo http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31 http://semanticscience.org/resource/SIO_000628 http://identifiers.org/ncbigene/1917 http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31 http://semanticscience.org/resource/SIO_000628 http://linkedlifedata.com/resource/umls/id/C0019196 http://rdf.disgenet.org/resource/gda/DGN83529e9894adcaade53aecc9f955cb31 http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://semanticscience.org/resource/SIO_001123 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#provenance http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://purl.org/dc/terms/description [To determine whether baseline LDL or HDL levels and statin use affect SVR rates, we retrospectively evaluated the IDEAL (Individualized Dosing Efficacy Versus Flat Dosing to Assess Optimal Pegylated Interferon Therapy) trial, in which 3070 treatment-naive, hepatitis C virus (HCV) genotype 1-infected patients were treated for up to 48 weeks in one of the following arms: (1) peginterferon (PEG-IFN) alfa-2b at 1.5 microg/kg/week with ribavirin (RBV) at 800 to 1400 mg/day, (2) PEG-IFN alfa-2b at 1.0 microg/kg/week with RBV at 800 to 1400 mg/day, or (3) PEG-IFN alfa-2a at 180 microg/week with RBV at 1000 to 1200 mg/day.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine. http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://purl.org/ontology/wi/core#evidence http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://semanticscience.org/resource/SIO_000772 http://identifiers.org/pubmed/20568303 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://www.w3.org/ns/prov#wasDerivedFrom http://rdf.disgenet.org/v5.0.0/void/BEFREE http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#assertion http://www.w3.org/ns/prov#wasGeneratedBy http://purl.obolibrary.org/obo/ECO_0000203 http://rdf.disgenet.org/v5.0.0/void/BEFREE http://purl.org/pav/importedOn 2017-02-19 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://purl.obolibrary.org/obo/ECO_0000212 http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#comment Gene-disease associations inferred from text-mining the literature. http://rdf.disgenet.org/v5.0.0/void/source_evidence_literature http://www.w3.org/2000/01/rdf-schema#label DisGeNET evidence - LITERATURE http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE#publicationInfo http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/dc/terms/created 2017-10-17T13:12:09+02:00 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/dc/terms/rights http://opendatacommons.org/licenses/odbl/1.0/ http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/dc/terms/rightsHolder http://rdf.disgenet.org/v5.0.0/void/IBIGroup http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/dc/terms/subject http://semanticscience.org/resource/SIO_000983 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/net/provenance/ns#usedData http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/authoredBy http://orcid.org/0000-0001-5999-6269 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/authoredBy http://orcid.org/0000-0002-7534-7661 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/authoredBy http://orcid.org/0000-0002-9383-528X http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/authoredBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/authoredBy http://orcid.org/0000-0003-1244-7654 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/createdBy http://orcid.org/0000-0003-0169-8159 http://rdf.disgenet.org/resource/nanopub/NP310497.RAZVh3kMOA9PWo6A63TyWQqsRomZO4d0yigtGd0GKJSHE http://purl.org/pav/version v5.0.0.0 http://rdf.disgenet.org/v5.0.0/void/disgenetv3.0rdf http://purl.org/pav/version v5.0.0